A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Nikki, Clausen, Maryam, Halpin, Rebecca A., Blackmore, Colin, Cai, Kang, Delpuech, Oona, Kohlmann, Alexander, Magnusson, Otto, March, Ruth, O’Neill, Daniel, Prakash, Kasthuri, Sherwood, James, Sundin, Tabetha, Swift, Jason, Tarakameh, Azar, Wijdicks, Marilou, Wise, Daniel, Fidock, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209156/
https://www.ncbi.nlm.nih.gov/pubmed/34135391
http://dx.doi.org/10.1038/s41598-021-92070-w
Descripción
Sumario:Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.

Ejemplares similares